Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 13 (1) , e12198
Abstract
Introduction: Subtle cognitive impairment (SCI) may appear before pathological changes surpass thresholds for abnormality. We aimed to investigate whether SCI could predict Alzheimer's pathologies and advancement. Methods: A total of 816 cognitively normal individuals were enrolled to assess the longitudinal neuropathological and clinical correlates of baseline SCI, via linear mixed‐effects and Cox proportional‐hazard models. Cross‐lagged panel models were used in specific time waves. Results: SCI individuals had a faster increase in brain amyloid burden and a higher risk of conversion. They also showed greater rates of cerebrospinal fluid (CSF) phosphorylated tau (p‐tau) 181 increase and glucose metabolism decrease. In addition, baseline SCI predicted worse clinical progression, whereas multi‐domain SCI advanced faster compared to the single domain group. Discussion: Baseline SCI could be an imperative prediction indicator of clinical and pathological progression. It enables cognitive measures to be informative at a very early stage and provided objective criteria for high‐risk population screening.Keywords
Funding Information
- National Natural Science Foundation of China (91849126)
- National Natural Science Foundation of China (81771148)
- National Institutes of Health (U01 AG024904)
This publication has 42 references indexed in Scilit:
- A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohortNeuroImage, 2012
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer diseaseNeurology, 2012
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging InitiativeArchives of General Psychiatry, 2011
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 2011
- Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.Neuropsychology, 2010
- Comparing predictors of conversion and decline in mild cognitive impairmentNeurology, 2010
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesStructural Equation Modeling: A Multidisciplinary Journal, 1999
- Cross-lagged panel correlation: Practice and promise.Journal of Applied Psychology, 1979